Brief: Neovacs To Continue Trials On New Vaccine Candidates For Allergies
09/03/2021 09:29
March 9 (Reuters) - NEOVACS SA ALNEV.PA :
* HAS PUT IN PLACE THE NECESSARY RESOURCES TO CONTINUE
CLINICAL
TRIALS RELATED TO DEVELOPMENT OF NEW VACCINE CANDIDATES IN THE
FIELD OF ALLERGY
Source text for Eikon: ID:nACT68139
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants